✦ LIBER ✦

Thyroid Hormone Action Is Disrupted by Bisphenol A as an Antagonist

✍ Scribed by Moriyama, Kenji; Tagami, Tetsuya; Akamizu, Takashi; Usui, Takeshi; Saijo, Misa; Kanamoto, Naotetsu; Hataya, Yuji; Shimatsu, Akira; Kuzuya, Hideshi; Nakao, Kazuwa

Book ID: 120236384
Publisher: Endocrine Society
Year: 2002
Tongue: English
Weight: 184 KB
Volume: 87
Category: Article
ISSN: 0021-972X
DOI: 10.1210/jc.2002-020209

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amphibian metamorphosis as a model for s

Amphibian metamorphosis as a model for studying endocrine disruption on vertebrate development: Effect of bisphenol A on thyroid hormone action

✍ Rachel A. Heimeier; Yun-Bo Shi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 953 KB

Protein encoded by v-erbA functions as a

Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist

✍ Damm, Klaus; Thompson, Catherine C.; Evans, Ronald M. 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 609 KB

Competitive binding to plasma thyroid ho

Competitive binding to plasma thyroid hormone transport proteins and thyroid disruption by phenylbutazone used as a probe

✍ Véronique Gayrard; Nicole Picard-Hagen; Catherine Viguié; Pierre-Louis Toutain 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 468 KB

A synchronized amphibian metamorphosis a

A synchronized amphibian metamorphosis assay as an improved tool to detect thyroid hormone disturbance by endocrine disruptors and apolar sediment extracts

✍ Arno C. Gutleb; Merijn Schriks; Leonie Mossink; J.H.J. van den Berg; Albertinka 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Hypotensive action of IgG preparations c

Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function)

✍ B. Jenei; G. Lázár; K. Bartha; G. A. Medgyesi 📂 Article 📅 1991 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 435 KB

753 Is combination therapy with an antic

753 Is combination therapy with an anticholinergic agent and an α1-adrenoceptor antagonist useful as first-line treatment in patients with benign prostatic hyperplasia complicated by overactive bladder? A randomized, prospective, comparative study using a urodynamic study

✍ Y. Matsukawa; R. Hattori; T. Mazima; T. Yamamoto; Y. Yoshino; M. Gotoh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 207 KB